Pharmacovigilance is a set of activities aimed at continuously evaluating all information related to drug safety and ensuring, for all medicines on the market, a favourable benefit/risk ratio for the population.

Spontaneous reports of suspected adverse reactions are an important source of information for pharmacovigilance activities, as they allow the detection of potential warning signs related to the use of all medicines available nationwide. Pharmacovigilance involves the entire community at various levels: patients, prescribers, healthcare professionals, pharmaceutical companies, institutions, and academia.
Reports of suspected adverse reactions can be made not only by healthcare professionals but also by citizens, using specific forms available on the website of the Ministry of Health

Slais S.r.l. provides the following email address for all issues related to adverse drug reports:farmacovigilanza@slais.it